230 related articles for article (PubMed ID: 18056394)
21. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis.
Kerfoot SM; Norman MU; Lapointe BM; Bonder CS; Zbytnuik L; Kubes P
J Immunol; 2006 May; 176(10):6225-34. PubMed ID: 16670333
[TBL] [Abstract][Full Text] [Related]
22. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice.
Küst B; Mantingh-Otter I; Boddeke E; Copray S
J Neuroimmunol; 2006 May; 174(1-2):92-100. PubMed ID: 16519950
[TBL] [Abstract][Full Text] [Related]
23. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
24. Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice.
Curtis JL; Sonstein J; Craig RA; Todt JC; Knibbs RN; Polak T; Bullard DC; Stoolman LM
J Immunol; 2002 Sep; 169(5):2570-9. PubMed ID: 12193727
[TBL] [Abstract][Full Text] [Related]
25. PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
Bill R; Döring A; Deutsch U; Engelhardt B
J Neuroimmunol; 2011 Mar; 232(1-2):207-8. PubMed ID: 21051092
[TBL] [Abstract][Full Text] [Related]
26. Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
Luu T; Cheung JF; Baccon J; Waldner H
PLoS One; 2021; 16(4):e0250340. PubMed ID: 33891644
[TBL] [Abstract][Full Text] [Related]
27. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
Sobel RA; Kuchroo VK
J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors.
Piccio L; Rossi B; Scarpini E; Laudanna C; Giagulli C; Issekutz AC; Vestweber D; Butcher EC; Constantin G
J Immunol; 2002 Feb; 168(4):1940-9. PubMed ID: 11823530
[TBL] [Abstract][Full Text] [Related]
32. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
33. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
34. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
35. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
36. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
Elo P; Tadayon S; Liljenbäck H; Teuho J; Käkelä M; Koskensalo K; Saunavaara V; Virta J; Veres TZ; Kiviniemi A; Saraste A; Marjamäki P; Airas L; Jalkanen S; Roivainen A
J Neuroinflammation; 2018 May; 15(1):128. PubMed ID: 29716612
[TBL] [Abstract][Full Text] [Related]
37. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
38. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
39. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
40. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]